๐
Livmarli
maralixibat
Cholestasis, Intrahepatic
๐ซ Withdrawn
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Treatment of progressive familial intrahepatic cholestasis type 2 (PFIC2)
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/livmarli-0